...
首页> 外文期刊>Biochimica et Biophysica Acta. General Subjects >MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway
【24h】

MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway

机译:MicroRNA-181a通过靶向MAPK-Snai2途径抑制涎腺腺样囊性癌转移

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background To date microRNAs and their contribution to the onset and propagation of salivary adenoid cystic carcinoma (SACC) are limited. The objective of this study was to identify miR-181a and its mechanism in the metastasis of SACC. Methods At first microarray and quantitative RT-PCR were used to investigate microRNA profiles and miR-181a in paired SACC cell lines with different metastatic potential. Then the effect of miR-181a on metastatic potential of SACC was investigated. MiR-181a target genes and Snai2 promoter activity were investigated using luciferase reporter gene assays. Western blot was used to detect MAPK-Snai2 pathway-related protein level. Results A panel of deregulated microRNAs (including miR-181a) was identified in paired of SACC cell lines. Functional analysis indicated that miR-181a inhibited SACC cell migration, invasion and proliferation in vitro, and it suppressed tumor growth and lung metastasis in vivo. Direct targeting of miR-181a to MAP2K1, MAPK1 and Snai2 was confirmed by luciferase reporter gene assays. MiR-181a mimic inhibited the expression of MAP2K1, MAPK1 and Snai2 in SACC cells. MAP2K1 or MAPK1 siRNA suppressed Snai2 gene promoter activity and reduced Snai2 expression and the metastatic potential of SACC cells. Conclusions Our results indicate that miR-181a plays an important role in the metastasis of SACC, and may serve as a novel therapeutic target for SACC. MiR-181a regulates the MAPK-Snai2 pathway both through direct cis-regulatory mechanism and through indirect trans-regulatory mechanism. General significance To our knowledge, this is the first study revealing that miR-181a deregulation mediated the metastasis of SACC by regulating MAPK-Snai2 pathway.
机译:背景技术迄今为止,microRNA及其对唾液腺腺样囊性癌(SACC)的发作和繁殖的作用是有限的。这项研究的目的是确定miR-181a及其在SACC转移中的机制。方法首先使用微阵列和定量RT-PCR研究成对的具有不同转移潜能的SACC细胞株中的microRNA谱和miR-181a。然后研究了miR-181a对SACC转移潜能的影响。使用萤光素酶报告基因检测了MiR-181a靶基因和Snai2启动子活性。免疫印迹用于检测MAPK-Snai2途径相关的蛋白水平。结果在成对的SACC细胞系中鉴定出一组失调的microRNA(包括miR-181a)。功能分析表明,miR-181a在体外抑制SACC细胞的迁移,侵袭和增殖,并在体内抑制肿瘤的生长和肺转移。萤光素酶报告基因检测证实了miR-181a直接靶向MAP2K1,MAPK1和Snai2。 MiR-181a模拟物抑制SACC细胞中MAP2K1,MAPK1和Snai2的表达。 MAP2K1或MAPK1 siRNA抑制Snai2基因启动子活性,并降低Snai2表达和SACC细胞的转移潜能。结论我们的结果表明,miR-181a在SACC的转移中起着重要的作用,并且可以作为SACC的新型治疗靶点。 MiR-181a通过直接的顺式调节机制和间接的反式调节机制来调节MAPK-Snai2途径。一般意义据我们所知,这是第一项揭示miR-181a失调通过调节MAPK-Snai2途径介导SACC转移的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号